Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Healthtrust
Moodys
Express Scripts
Chubb
Merck
AstraZeneca
Harvard Business School
Argus Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,146,719

« Back to Dashboard

Summary for Patent: 4,146,719
Title: Piperazinyl derivatives of quinoline carboxylic acids
Abstract:This invention relates to new compounds of value as antibacterial agent. More particularly, it relates to piperazinyl derivatives of quinoline carboxylic acids, the hydrates, and the acid addition salts thereof.
Inventor(s): Irikura; Tsutomu (Tokyo, JP)
Assignee: Kyorin Seiyaku Kabushiki Kaisha (Tokyo, JP)
Application Number:05/878,600
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 4,146,719

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,146,719

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan52/56219May 16, 1977

International Patents Family Members for US Patent 4,146,719

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 3271378 ➤ Subscribe
Australia 512940 ➤ Subscribe
Belgium 863429 ➤ Subscribe
Canada 1178961 ➤ Subscribe
Germany 2804097 ➤ Subscribe
France 2391210 ➤ Subscribe
United Kingdom 1574285 ➤ Subscribe
Hong Kong 10385 ➤ Subscribe
Hungary 176265 ➤ Subscribe
Japan S53141286 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fuji
Express Scripts
US Department of Justice
Johnson and Johnson
McKesson
Teva
Daiichi Sankyo
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot